Abstract
With the near availability of a cloned Caenorhabditis elegans ORFeome, the development of a high-throughput worm interactome mapping project has now become feasible. After reviewing the increasing interest for C. elegans as a model organism, from ”classical“ biology to the post-genomic era, this article presents the early steps accomplished for the generation of a C. elegans protein interaction map using the twohybrid system. Different approaches have been examined in order to determine the appropriate strategy to screen protein-protein interactions on a large scale. Our version of the two-hybrid system has been used to generate prototype maps for 4 different C. elegans biological modules (vulval development, proteasome, DNA repair / cell cycle and dauer). Those pilot projects helped us developing experimental procedures to avoid most false positive protein interactions while covering a satisfactory proportion of geniune interactions. In silico analysis and experimental validation of the potential protein interactions have already demonstrated biological relevance for some of the networks of interactions obtained.
Keywords: Caenorhabditis elegans orfeome
Current Genomics
Title: The Caenorhabditis elegans Interactome Mapping Project
Volume: 3 Issue: 2
Author(s): Jean-Francois Rual, Philippe Lamesch, Jean Vandenhaute and Marc Vidal
Affiliation:
Keywords: Caenorhabditis elegans orfeome
Abstract: With the near availability of a cloned Caenorhabditis elegans ORFeome, the development of a high-throughput worm interactome mapping project has now become feasible. After reviewing the increasing interest for C. elegans as a model organism, from ”classical“ biology to the post-genomic era, this article presents the early steps accomplished for the generation of a C. elegans protein interaction map using the twohybrid system. Different approaches have been examined in order to determine the appropriate strategy to screen protein-protein interactions on a large scale. Our version of the two-hybrid system has been used to generate prototype maps for 4 different C. elegans biological modules (vulval development, proteasome, DNA repair / cell cycle and dauer). Those pilot projects helped us developing experimental procedures to avoid most false positive protein interactions while covering a satisfactory proportion of geniune interactions. In silico analysis and experimental validation of the potential protein interactions have already demonstrated biological relevance for some of the networks of interactions obtained.
Export Options
About this article
Cite this article as:
Rual Jean-Francois, Lamesch Philippe, Vandenhaute Jean and Vidal Marc, The Caenorhabditis elegans Interactome Mapping Project, Current Genomics 2002; 3 (2) . https://dx.doi.org/10.2174/1389202024605206
| DOI https://dx.doi.org/10.2174/1389202024605206 |
Print ISSN 1389-2029 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Autologous CD19-Targeted Chimeric Antigen Receptor (CAR)T-Cells as
the Future of Systemic Lupus Erythematosus Treatment
Current Rheumatology Reviews Toxicities of Immunosuppressive Treatment of Autoimmune Neurologic Diseases
Current Neuropharmacology Design, Synthesis and Potent Pharmaceutical Applications of Glycodendrimers:A Mini Review
Current Drug Discovery Technologies Current Review of Small Molecule Ret Kinase Inhibitors
Mini-Reviews in Medicinal Chemistry Psychiatric/Psychosocial Rehabilitation (PSR) in Relation to Residential Environments: Housing and Homelessness
Current Psychiatry Reviews Fibrosis as a Therapeutic Target Post-Myocardial Infarction
Current Pharmaceutical Design B Cell Depletion with Rituximab in Graves Disease and Associated Orbitopathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Adenosine-to-Inosine RNA Editing: Perspectives and Predictions
Mini-Reviews in Medicinal Chemistry IL-15 and HIV Infection: Lessons for Immunotherapy and Vaccination
Current HIV Research Human Neural Stem and Progenitor Cells: In Vitro and In Vivo Properties, and Potential for Gene Therapy and Cell Replacement in the CNS
Current Gene Therapy QSAR and Molecular Docking Studies on a Series of 1-Amino-5H-pyrido [4, 3-b]indol-4-carboxamides Acting as Janus Kinase 2 (JAK2) Inhibitors
Letters in Drug Design & Discovery Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Mucosal Repair and COX-2 Inhibition
Current Pharmaceutical Design New Developments in the Management of Pleural Effusions
Current Respiratory Medicine Reviews Aptamer-based Emerging Tools for Viral Biomarker Detection: A Focus on SARS-CoV-2
Current Medicinal Chemistry Skeletal Involvement in Antiphospholipid Syndrome
Current Rheumatology Reviews Molecular Chaperone Activity and Biological Regulatory Actions of the TPR-Domain Immunophilins FKBP51 and FKBP52
Current Protein & Peptide Science Androgen Receptor: Past, Present and Future
Current Drug Targets Azoles as Effective Antifungal Agents: Trends, Scope and Relevance
The Natural Products Journal Innate Immune Receptors and IRF Family Transcription Factors
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents





